ciprofloxacin has been researched along with arginine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Irie, S; Kobayashi, I; Nakayama, H; Notomi, T; Okadome, A; Saika, T; Tanaka, M; Tsunoda, Y | 1 |
| Bax, BD; Brown, KK; Chan, PF; Eggleston, DS; Fosberry, A; Gentry, DR; Giordano, I; Gorrec, F; Gwynn, MN; Hann, MM; Hennessy, A; Hibbs, M; Huang, J; Jones, E; Jones, J; Lewis, CJ; May, EW; Pearson, ND; Saunders, MR; Shen, C; Shillings, A; Singh, O; Spitzfaden, CE; Theobald, AJ; Wohlkonig, A | 1 |
| Haque, SS | 1 |
| Ding, Y; Gu, S; Li, L; Zhang, F; Zhang, Z | 1 |
| Abo-Riya, M; Infante, MR; Manresa, MA; Muzzalupo, R; Pérez, L; Pinazo, A; Tavano, L | 1 |
| Chen, F; Tang, Y; Wang, C; Wang, J; Xu, Y; Zheng, H | 1 |
| Kayış, U; Kaynak Onurdağ, F; Ökten, S | 1 |
| Cendra, MDM; Gazvoda, L; Hrescak, J; Jaklic, B; Kurtjak, M; Moya-Andérico, L; Torrents, E; Vukomanovic, M | 1 |
| Beigverdi, R; Emaneini, M; Halimi, S; Jabalameli, F; Siroosi, M | 1 |
1 review(s) available for ciprofloxacin and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for ciprofloxacin and arginine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.
Topics: Amino Acid Substitution; Anti-Infective Agents; Arginine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Japan; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Proline | 2004 |
Type IIA topoisomerase inhibition by a new class of antibacterial agents.
Topics: Anti-Bacterial Agents; Apoenzymes; Arginine; Aspartic Acid; Binding Sites; Catalytic Domain; Ciprofloxacin; Crystallography, X-Ray; DNA; DNA Cleavage; DNA Gyrase; DNA, Superhelical; Drug Design; Drug Resistance; Escherichia coli; Manganese; Models, Molecular; Protein Conformation; Quinolines; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2010 |
Impact of nitric oxide precursor L-arginine on oxidative stress against typhoid.
Topics: Animals; Arginine; Ciprofloxacin; Lipid Peroxidation; Liver; Malondialdehyde; Mice; Nitric Oxide; Oxidative Stress; Typhoid Fever | 2012 |
A novel sensor based on electropolymerization of β-cyclodextrin and L-arginine on carbon paste electrode for determination of fluoroquinolones.
Topics: Acids; Arginine; beta-Cyclodextrins; Blood Chemical Analysis; Carbon; Ciprofloxacin; Drug Stability; Electrochemistry; Electrodes; Fluoroquinolones; Humans; Microscopy, Electron, Scanning; Molecular Structure; Polymerization; Reproducibility of Results | 2013 |
Cationic vesicles based on biocompatible diacyl glycerol-arginine surfactants: physicochemical properties, antimicrobial activity, encapsulation efficiency and drug release.
Topics: Anti-Infective Agents; Arginine; Bacteria; Biocompatible Materials; Cations; Chemical Phenomena; Ciprofloxacin; Diglycerides; Drug Liberation; Fluorouracil; Hydrodynamics; Hydrogen-Ion Concentration; Liposomes; Microbial Sensitivity Tests; Particle Size; Static Electricity; Surface-Active Agents | 2014 |
Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.
Topics: Acinetobacter baumannii; Acute-Phase Proteins; Amino Acid Sequence; Animals; Anti-Infective Agents; Arginine; Carrier Proteins; Ciprofloxacin; Cysteine; Defensins; Drug Resistance, Microbial; Humans; Lipopolysaccharides; Membrane Glycoproteins; Mice; Models, Molecular; Molecular Structure; NF-kappa B; Protein Binding; Protein Conformation; RAW 264.7 Cells; Signal Transduction; Structure-Activity Relationship; Toll-Like Receptor 4 | 2019 |
[Effect of Phenylalanine-arginine-beta-naphthylamide to Ciprofloxacin Minimum Inhibitory Concentration Values and Expression of Efflux Pump System Genes in Acinetobacter baumannii Isolates].
Topics: Acinetobacter baumannii; Arginine; Ciprofloxacin; Dipeptides; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Naphthalenes; Phenylalanine | 2021 |
Development of a ternary cyclodextrin-arginine-ciprofloxacin antimicrobial complex with enhanced stability.
Topics: Anti-Bacterial Agents; Arginine; beta-Cyclodextrins; Ciprofloxacin; Cyclodextrins | 2022 |
Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Topics: Alginates; Amikacin; Anti-Bacterial Agents; Arginine; Biofilms; Ciprofloxacin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Nitrates; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |